Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Regulatory News (IBT)

Share Price Information for Int.biotech. (IBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 642.00
Bid: 638.00
Ask: 646.00
Change: 10.00 (1.58%)
Spread: 8.00 (1.254%)
Open: 636.00
High: 642.00
Low: 636.00
Prev. Close: 632.00
IBT Live PriceLast checked at -
International Biotechnology is an Investment Trust

To achieve capital growth through investing in high growth, development stage biotechnology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

7 Dec 2016 12:44

RNS Number : 2162R
Intl. Biotechnology Trust PLC
07 December 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

International Biotechnology Trust plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Lazard Asset Management LLC

4. Full name of shareholder(s)  (if different from 3.):iv

JP Morgan Chase - SWIFT

Mellon Trust

Morgan Guaranty - Personal Custody

Northern Trust Co

State Street Bank - Custodian ETC

State Street Bank - Master Tr - ETC

State Street Bank - Custody Master Trust

 

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

06 December 2016

6. Date on which issuer notified:

07 December 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

Decrease from 25% to 24%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0004559349

9,396,050

9,296,050

24.758%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

9,296,050

24.758%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Lazard Asset Management LLC controls all the voting rights held of this issuer.

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Legal & Compliance Department

15. Contact telephone number:

0207 448 2085

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUBSURNOAURAA
Date   Source Headline
16th Mar 20235:10 pmRNSTransaction in Own Shares
15th Mar 20235:12 pmRNSTransaction in Own Shares
15th Mar 20234:24 pmRNSTransaction in Own Shares
13th Mar 20234:10 pmRNSTransaction in Own Shares
13th Mar 202312:32 pmRNSPortfolio Update
7th Mar 20234:59 pmRNSTransaction in Own Shares
2nd Mar 20235:29 pmRNSTransaction in Own Shares
21st Feb 20237:00 amRNSPortfolio Update
13th Feb 20237:00 amRNSInvestment Management Update
7th Feb 20239:00 amRNSDirector Declaration
2nd Feb 20237:00 amRNSPortfolio Update
23rd Jan 20235:22 pmRNSAppointment of Non-executive Director
23rd Jan 20237:00 amRNSPortfolio Update
3rd Jan 20237:00 amRNSBlock listing Interim Review
19th Dec 20229:00 amRNSPortfolio Update
14th Dec 20227:00 amRNSPortfolio Update
12th Dec 20222:23 pmRNSPortfolio Update
8th Dec 20227:47 amEQSHardman & Co Research on International Biotechnology Trust (IBT): Low FDA activity may drive further M&A
6th Dec 20224:24 pmRNSDividend Declaration
6th Dec 20224:18 pmRNSResult of AGM
1st Dec 20222:38 pmRNSTotal Voting Rights
17th Nov 20228:00 amRNSPortfolio Update
9th Nov 20224:48 pmRNSTransaction in Own Shares
8th Nov 20224:41 pmRNSTransaction in Own Shares
7th Nov 20225:20 pmRNSTransaction in Own Shares
4th Nov 20224:40 pmRNSTransaction in Own Shares
3rd Nov 20224:57 pmRNSTransaction in Own Shares
1st Nov 20225:22 pmRNSTransaction in Own Shares
1st Nov 202211:26 amRNSTotal Voting Rights
1st Nov 20227:00 amRNSAnnual Financial Report
31st Oct 20225:20 pmRNSTransaction in Own Shares
27th Oct 20225:33 pmRNSTransaction in Own Shares
26th Oct 20224:39 pmRNSTransaction in Own Shares
25th Oct 20228:00 amRNSPortfolio Update
24th Oct 20225:12 pmRNSTransaction in Own Shares
18th Oct 20225:36 pmRNSTransaction in Own Shares
17th Oct 20221:16 pmRNSTransaction in Own Shares
13th Oct 20225:55 pmRNSTransaction in Own Shares
13th Oct 20227:00 amRNSKepler Trust Intelligence: New Research
3rd Oct 202212:07 pmRNSTotal Voting Rights
30th Sep 20227:00 amRNSCompliance with the Market Abuse Regulation
20th Sep 20225:22 pmRNSTransaction in Own Shares
20th Sep 20228:00 amRNSPortfolio Update
25th Aug 20228:30 amRNSPortfolio Update
1st Aug 202211:12 amRNSTotal Voting Rights
22nd Jul 20223:29 pmRNSDividend Declaration
20th Jul 20229:00 amRNSPortfolio Update
11th Jul 20221:26 pmRNSReplacement: Transaction in Own Shares
7th Jul 20225:45 pmRNSTransaction in Own Shares
6th Jul 20225:16 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.